Earnings
PHIO
2.910
-2.68%
-0.080
Currencies: USD
Items
Net Income
Depreciation and Amortization
Deferred Tax
Unamortized Expenditures
Accrued Expenses
Share-based Compensation
Assets Disposal
Financial Expenses
Investment Loss
Working Capital Change
Other Items
Operating Activities
Purchases of Fixed Assets
Proceeds from Disposal of Fixed Assets
Investment Expenditure
Investment Income
Other Investing Activities
Investing Activities
Issuance of Capital Stock
Issuance of Bonds
Proceeds from Borrowings
Dividend Payments
Repayment of Borrowings
Buyback Payments
Stock Incentive Compensation
Other Financing Activities
Financing Activities
Effect of Exchange Rate Changes 
Net Increase in Cash,Cash Equivalents
FY 2019-12-31
-8.91M
67.00K
--
--
--
--
409.00K
--
--
-213.00K
--
-8.64M
-72.00K
--
--
--
--
-72.00K
781.00K
-6000.00
--
--
--
--
--
--
772.00K
--
-7.95M
FY 2018-12-31
-7.36M
81.00K
0.00
--
--
--
282.00K
--
--
-523.00K
--
-7.52M
-5000.00
--
--
--
0.00
-5000.00
18.82M
--
--
--
--
--
--
--
18.82M
--
11.30M
FY 2017-12-31
-12.45M
70.00K
-1.62M
--
--
--
5.02M
--
--
-530.00K
--
-9.51M
-203.00K
--
--
--
100.00K
-103.00K
292.00K
--
--
--
--
--
--
--
292.00K
--
-9.32M
FY 2016-12-31
-8.99M
53.00K
--
--
--
--
747.00K
--
--
434.00K
--
-7.76M
-4000.00
--
--
--
5.35M
5.35M
10.20M
--
--
--
--
--
--
--
10.20M
--
7.79M
FY 2015-12-31
-10.22M
77.00K
--
--
--
--
1.76M
--
--
1.07M
--
-7.32M
-57.00K
--
--
--
-5.50M
-5.56M
9.30M
--
--
--
--
--
--
--
9.49M
--
-3.38M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out PHIO latest annual and quarterly financial reports. There are also historical financial reports for you to reference. You can analyze Phio Pharmaceuticals Corp recent business situations by check its cash flow statements, balance sheets, income statements and other tables. Comprehensive data may help you to understand and analyze PHIO development prospects in various aspects, and this information may help you to better grasp the Phio Pharmaceuticals Corp operation.